Knockdown of lncRNA HOXD-AS2 Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells.

Chen F, Zhao RR, Li Q, Chen ZH, Luo C

Open source

DOI
10.1155/2022/9337647
Published
2022
Container
Evidence-based complementary and alternative medicine : eCAM
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/9337647,
  title = {Knockdown of lncRNA HOXD-AS2 Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells.},
  author = {Chen F and Zhao RR and Li Q and Chen ZH and Luo C},
  year = {2022},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2022/9337647},
  url = {https://doi.org/10.1155/2022/9337647}
}

RIS

TY  - JOUR
TI  - Knockdown of lncRNA HOXD-AS2 Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells.
AU  - Chen F
AU  - Zhao RR
AU  - Li Q
AU  - Chen ZH
AU  - Luo C
PY  - 2022
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2022/9337647
UR  - https://doi.org/10.1155/2022/9337647
ER  - 

APA

F, C., RR, Z., Q, L., ZH, C., & C, L. (2022). Knockdown of lncRNA HOXD-AS2 Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2022/9337647

Source records